Legal Services Advertising

Trial lawyers and aggregators increasingly spend large sums of money on television, digital, and print advertising to recruit new clients for class action lawsuits. Much of this advertising is conducted by aggregators: businesses that recruit potential plaintiffs and then sell their information to law firms.

The Problem

Consumers see doomsday ads about the lethal effects of medications or even general medical injury, and consequently stop using their medicine. This is often done without consulting a doctor, causing health problems for the patients and increasing litigation risk for the product manufacturers. These over-the-top advertisements from personal injury attorneys with catchy jingles and toll-free numbers pose a serious danger. These ads undermine the simple notion that physicians and health care providers, not personal injury lawyers or the “aggregators” who run the ads for the lawyers, should dispense medical advice. The reason why trial lawyers pump significant money into these ad buys is because, armed with more clients, they can boost settlements and payouts when they go after large corporations. This leads to larger contingency fees for themselves.

ATRA’s Position

ATRA supports legislation that places reasonable regulations regarding deceptive or misleading lawsuit or legal services advertisements.

Search Through ATRA Reforms

Search through all of ATRA's reforms around Legal Services Advertising

No related legislation or reform items to display.



Legal Services Advertising News and Press

Explore ATRA's most recent press releases and blogs around Legal Services Advertising

New Report Exposes Oregon’s Soaring Trial Lawyer Ad Spending and Rising Litigation Risks

The American Tort Reform Association released a new analysis today reveali...

The High Cost of Junk Science Verdicts in Los Angeles

This op-ed was authored by ATRA’s Lauren Sheets Jarrell and was orig...

Letter-to-the-Editor – A Better Target for Prasad: Personal Injury Ads

This letter-to-the-editor was published by the Wall Street Journal and app...

Search Resources

Search through all of ATRA's Amicus Briefs, Reports, and Other Resources around Legal Services Advertising
Search All
States
Status
Post Types
Date
Cottrell v. Alcon Laboratories
(3rd Cir., filed September 28, 2016): Arguing that the plaintiffs’ speculative claim that they might have paid less for a medication if defendan...
3rd Circuit
  • Court Ruled Against ATRA's Position iconCourt Ruled Against ATRA's Position
Eike v. Allergan
(7th Cir., filed October 18, 2016): Arguing that the plaintiffs’ speculative claim that they might have paid less for a medication if defendants...
7th Circuit
  • Court Ruled in Favor of ATRA's Position iconCourt Ruled in Favor of ATRA's Position
BNSF v. Tyrell
(US., filed October 28, 2016): Arguing that the Montana Supreme Court improperly applied the Daimler personal jurisdiction requirements, which state t...
SCOTUS
  • Court Granted Cert iconCourt Granted Cert
In re Zoloft Litigation
(3rd Cir., filed October 18, 2016): Arguing that an expert cannot premise a causation analysis on a single statistically-significant association when ...
3rd Circuit
  • Court Ruled in Favor of ATRA's Position iconCourt Ruled in Favor of ATRA's Position



The American Tort Reform Association is the nation’s first organization dedicated exclusively to reforming the civil justice system through education and legislative enactment.

To receive occasional updates from ATRA, enter your email address:
By subscribing, you agree to our Privacy Policy and consent to receive updates.
© 2026 ATRA. All rights reserved.